L471-0825 Screening compound: N-cycloheptyl-3-[4-(4-methylpiperidin-1-yl)phenyl]-1,2,4-oxadiazole-5-carboxamide

L471-0825 Screening compound: N-cycloheptyl-3-[4-(4-methylpiperidin-1-yl)phenyl]-1,2,4-oxadiazole-5-carboxamide
L471-0825 Screening compound: N-cycloheptyl-3-[4-(4-methylpiperidin-1-yl)phenyl]-1,2,4-oxadiazole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L471-0825
N-cycloheptyl-3-[4-(4-methylpiperidin-1-yl)phenyl]-1,2,4-oxadiazole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L471-0825

Molecular Formula

C22H30N4O2 (C22 H30 N4 O2)

Compound Name

N-cycloheptyl-3-[4-(4-methylpiperidin-1-yl)phenyl]-1,2,4-oxadiazole-5-carboxamide

IUPAC name

N-cycloheptyl-3-[4-(4-methylpiperidin-1-yl)phenyl]-124-oxadiazole-5-carboxamide

SMILES

CC(CC1)CCN1c(cc1)ccc1-c1noc(C(NC2CCCCCC2)=O)n1

InChI

InChI=1S/C22H30N4O2/c1-16-12-14-26(15-13-16)19-10-8-17(9-11-19)20-24-22(28-25-20)21(27)23-18-6-4-2-3-5-7-18/h8-11,16,18H,2-7,12-15H2,1H3,(H,23,27)

InChI Key

AZKLNLRAJVTKDP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27255196

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

382.51

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.321

Distribution Coefficient, logD

5.321

Water Solubility, LogSw

-5.20

Polar Surface Area

59.838

Acid Dissociation Constant (pKa)

13.64

Base Dissociation Constant (pKb)

3.44

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

59.10

L471-0825 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with L471-0825 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L471-0825?
Check Price and Availability of L471-0825, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L471-0825 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L471-0825
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L471-0825
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L471-0825 available by request